Businesses have announced buybacks of shares this season at a rate of more than $5 billion a day. The buyback boom has seen by investors as a sign of confidence among business executives.
According to an analysis of regulatory filings by TrimTabs Investment Research, insiders sold $8.4 billion of their shares in May and $9.2 billion in June. This is the biggest 2 months period of insider selling within a year.
Large banks such as Wells Fargo (WFC), JPMorgan Chase (JPM) and Bank of America (BAC) pour more money into repurchases. Each said they would buy back at least $20 billion of their own stock. Apple (AAPL) also announced plans last quarter for $100 billion in buybacks.
However, according to an analysis from SEC Commissioner Robert Jackson Jr, insider selling increases immediately after buybacks are unveiled. The study found that in 2017 and 2018, the percentage of insider selling more than doubled just after buyback announcements. Investors – please be on a look out for the insider sells.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for BAC moved into overbought territory on September 14, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Following a +1.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAC advanced for three days, in 222 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
BAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 173 of 286 cases where BAC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 70 cases where BAC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 53%.
The Momentum Indicator moved below the 0 level on September 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BAC as a result. In 45 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
The Moving Average Convergence Divergence Histogram (MACD) for BAC turned negative on August 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 21 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 47%.
BAC moved below its 50-day moving average on September 14, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Tickeron SMR rating for this company is 2 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating fairly steady price growth. BAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 19, placing this stock slightly worse than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.506) is normal, around the industry mean (1.907). P/E Ratio (13.734) is within average values for comparable stocks, (15.269). Projected Growth (PEG Ratio) (0.899) is also within normal values, averaging (1.343). Dividend Yield (0.020) settles around the average of (0.025) among similar stocks. P/S Ratio (3.743) is also within normal values, averaging (3.933).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks